Lossie A C, Whitney M M, Amidon D, Dong H J, Chen P, Theriaque D, Hutson A, Nicholls R D, Zori R T, Williams C A, Driscoll D J
R C Philips Unit and Division of Genetics, Department of Pediatrics, University of Florida, Gainesville, FL 32610-0296, USA.
J Med Genet. 2001 Dec;38(12):834-45. doi: 10.1136/jmg.38.12.834.
Angelman syndrome (AS) is a severe neurobehavioural disorder caused by defects in the maternally derived imprinted domain located on 15q11-q13. Most patients acquire AS by one of five mechanisms: (1) a large interstitial deletion of 15q11-q13; (2) paternal uniparental disomy (UPD) of chromosome 15; (3) an imprinting defect (ID); (4) a mutation in the E3 ubiquitin protein ligase gene (UBE3A); or (5) unidentified mechanism(s). All classical patients from these classes exhibit four cardinal features, including severe developmental delay and/or mental retardation, profound speech impairment, a movement and balance disorder, and AS specific behaviour typified by an easily excitable personality with an inappropriately happy affect. In addition, patients can display other characteristics, including microcephaly, hypopigmentation, and seizures.
We restricted the present study to 104 patients (93 families) with a classical AS phenotype. All of our patients were evaluated for 22 clinical variables including growth parameters, acquisition of motor skills, and history of seizures. In addition, molecular and cytogenetic analyses were used to assign a molecular class (I-V) to each patient for genotype-phenotype correlations.
In our patient repository, 22% of our families had normal DNA methylation analyses along 15q11-q13. Of these, 44% of sporadic patients had mutations within UBE3A, the largest percentage found to date. Our data indicate that the five molecular classes can be divided into four phenotypic groups: deletions, UPD and ID patients, UBE3A mutation patients, and subjects with unknown aetiology. Deletion patients are the most severely affected, while UPD and ID patients are the least. Differences in body mass index, head circumference, and seizure activity are the most pronounced among the classes.
Clinically, we were unable to distinguish between UPD and ID patients, suggesting that 15q11-q13 contains the only significant maternally expressed imprinted genes on chromosome 15.
天使综合征(AS)是一种严重的神经行为障碍,由位于15q11 - q13的母源印记区域缺陷引起。大多数患者通过以下五种机制之一患上AS:(1)15q11 - q13的大片段间质缺失;(2)15号染色体的父源单亲二倍体(UPD);(3)印记缺陷(ID);(4)E3泛素蛋白连接酶基因(UBE3A)突变;或(5)不明机制。这些类型的所有典型患者均表现出四个主要特征,包括严重发育迟缓及/或智力障碍、严重语言障碍、运动和平衡障碍,以及以易激惹性格和不适当愉快情绪为特征的AS特异性行为。此外,患者还可表现出其他特征,包括小头畸形、色素减退和癫痫发作。
我们将本研究限制在104例具有典型AS表型的患者(93个家庭)。对所有患者评估了22项临床变量,包括生长参数、运动技能获得情况和癫痫发作史。此外,使用分子和细胞遗传学分析为每位患者确定分子类型(I - V),以进行基因型 - 表型相关性研究。
在我们的患者资料库中,22%的家庭15q11 - q13的DNA甲基化分析结果正常。其中,44%的散发性患者在UBE3A基因内存在突变,这是迄今为止发现的最大比例。我们的数据表明,五种分子类型可分为四个表型组:缺失型、UPD和ID型患者、UBE3A突变型患者以及病因不明的患者。缺失型患者受影响最严重,而UPD和ID型患者受影响最小。体重指数、头围和癫痫发作活动在各类型之间差异最为明显。
临床上,我们无法区分UPD和ID型患者,这表明15q11 - q13包含15号染色体上唯一重要的母源表达印记基因。